Emory UAEM

UAEM is continuing its tradition of organizing a Pre-Health Gala this semester open to undergraduates, with a focus on first year students interested in pursuing pre-health careers. This is an opportunity to become familiarized with some of the pre-health clubs offered at Emory, engage in discussions with peers that may inspire future collaborations, and indicate interest in joining new organizations. Each club participating in the gala will give a ~2-minute overview of their organization, after which there will be an opportunity to join the private, direct follow-up Zoom meetings for any club of interest. This event offers a chance to meet fellow students interested in health careers and learn about opportunities to get involved in the Emory pre-health community.

The Pre-Health Gala will be held this Thursday, October 1st, from 6-7:30PM via Zoom (https://emory.zoom.us/J/4668507249)

The following clubs will be represented:

Emory Universities Allied for Essential Medicines (UAEM)
Doctors Without Borders
American Society for Biochemistry and Molecular Biology (ASBMB)
Remote Area Medical (RAM)
Emory Pre-Medical Association (EPMA)
Emory American Student Dental Association (EASDA)
Phi Delta Epsilon
Health and Development in Guatemala
Pre-Physician Assistant Society
Student Alliance for Health Involvement at Emory (SAHI)
Global Medical Brigades
Emory Undergraduate Service Journal Club (EUSJC)
Emory MEDLIFE
Emory Children's Healthcare Outreach (ECHO)

We hope you will join us at this event!

Universities Allied for Essential Medicines Emory chapter is recruiting graduate student board members for this academic year.

If you are interested in applying to the current open positions, please apply here: https://bit.ly/2mZPMW2

Also, please like and follow our page for updates!
page : https://www.facebook.com/EmoryUAEM/

https://www.statnews.com/2019/03/01/ultomiris-innovation-patent-protection/

Ultomiris: Can drug innovation be too expensive? - STAT Alexion's blockbuster drug Soliris will soon go off patent. It's new drug, Ultomiris, does the same task. Should this innovation get full patent protection?

The WHO released a comprehensive report looking at the pricing and accessibility of cancer medicines and calls for improvement. Some industry proponents disagree.

Here is a summary (~5 min read): https://www.statnews.com/pharmalot/2019/01/23/who-cancer-drugs-prices/?utm_source=STAT+Newsletters&utm_campaign=66fd25de8a-Pharmalot&utm_medium=email&utm_term=0_8cab1d7961-66fd25de8a-150898913

The bottom of the article has a link to the entire WHO report.

WHO says cancer drug prices are 'impairing' access to treatment - STAT The 117-page report concluded that the “market structure for cancer medicines is characterized by "imperfect competition."